Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
This determines how much liquid you draw per dose
By taking a patient, safety-focused approach, youll be well-positioned to access retatrutide through legitimate channels when it becomes available
However, if you have medical conditions or specific concerns, please consult your doctor with the list of ingredients found on the website
Patients considering the use of compounded semaglutide should fully educate themselves by talking to their healthcare provider about the safety and efficacy of this form of medication before any use
The Phase 3 TRIUMPH program, ongoing through 2026, is evaluating retatrutide across multiple patient populations: TRIUMPH-1: Adults with obesity without diabetes TRIUMPH-2: Adults with type 2 diabetes TRIUMPH-4: Adults with obesity and knee osteoarthritis TRIUMPH CVOT: Cardiovascular outcomes trial The December 2025 TRIUMPH-4 readout reported an average weight loss of 28.7 percent of body weight at 68 weeks the highest reported weight loss percentage in any obesity drug trial to date
